Low-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia : A randomised controlled trial
BACKGROUND: Even shallow residual neuromuscular block [i.e. train-of-four (TOF) ratio around 0.6] is harmful. It can be effectively antagonised by small doses of neostigmine, but reports are limited to intravenous anaesthesia. Inhalational anaesthesia may enhance neuromuscular block and delay recovery. It is not known whether low doses of neostigmine are still effective in the context of inhalational anaesthesia.
OBJECTIVE: To assess the effectiveness of low doses of neostigmine to antagonise shallow atracurium block during desflurane anaesthesia.
DESIGN: Randomised controlled trial, four groups.
SETTING: Single centre, University Hospital, May 2010 to March 2011.
PARTICIPANTS: Forty-eight American Society of Anesthesiologists I-III patients undergoing desflurane anaesthesia.
INTERVENTION: At TOF ratio 0.6, patients were randomised to one of four treatments (physiological saline, 10, 20 or 30 µg kg(-1) neostigmine, n = 12 for each).
MAIN OUTCOME MEASURE: Primary efficacy endpoint: time interval between study drug injection and a TOF ratio more than 0.9 using acceleromyography. Secondary efficacy endpoint: neuromuscular recovery after 5 and 10 min.
RESULTS: After physiological saline, the time interval [median (range)] between a TOF ratio of 0.6 and 0.9 was 14 (7 to 18) min. After 10, 20 and 30 µg kg(-1) neostigmine, it was reduced to 5 (3 to 8) min, 5 (3 to 10) and 4 (2 to 6) min, respectively (P < 0.001 compared to physiological saline). At 5 min after physiological saline, the TOF ratio [mean (SD)] was 0.73 (0.05) and 0.91 (0.06), 0.90 (0.10), 0.96 (0.02) after neostigmine 10, 20 or 30 µg kg(-1), respectively (P < 0.01 compared to physiological saline). At 10 min after physiological saline, the TOF ratio was 0.86 (0.08) and 1.0 (0), 0.98 (0.03), 1.0 (0) after neostigmine 10, 20 or 30 µg kg(-1), respectively (P < 0.01 compared to physiological saline).
CONCLUSION: Under desflurane anaesthesia, neostigmine 10 µg kg(-1) is effective in antagonising shallow atracurium block. Compared to no neostigmine, the time to a TOF ratio more than 0.9 was shortened and neuromuscular recovery at 5 and 10 min was more advanced.
TRIAL REGISTRATION: EudraCT Nr. is 2009 -018214-19.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
|---|---|
| Enthalten in: |
European journal of anaesthesiology - 30(2013), 10 vom: 01. Okt., Seite 594-8 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fuchs-Buder, Thomas [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 21.12.2015 Date Revised 02.12.2018 published: Print EudraCT: 2009-018214-19 Citation Status MEDLINE |
|---|
| doi: |
10.1097/EJA.0b013e3283631652 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM228678390 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM228678390 | ||
| 003 | DE-627 | ||
| 005 | 20231224080454.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/EJA.0b013e3283631652 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0762.xml |
| 035 | |a (DE-627)NLM228678390 | ||
| 035 | |a (NLM)23803594 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fuchs-Buder, Thomas |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Low-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia |b A randomised controlled trial |
| 264 | 1 | |c 2013 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.12.2015 | ||
| 500 | |a Date Revised 02.12.2018 | ||
| 500 | |a published: Print | ||
| 500 | |a EudraCT: 2009-018214-19 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Even shallow residual neuromuscular block [i.e. train-of-four (TOF) ratio around 0.6] is harmful. It can be effectively antagonised by small doses of neostigmine, but reports are limited to intravenous anaesthesia. Inhalational anaesthesia may enhance neuromuscular block and delay recovery. It is not known whether low doses of neostigmine are still effective in the context of inhalational anaesthesia | ||
| 520 | |a OBJECTIVE: To assess the effectiveness of low doses of neostigmine to antagonise shallow atracurium block during desflurane anaesthesia | ||
| 520 | |a DESIGN: Randomised controlled trial, four groups | ||
| 520 | |a SETTING: Single centre, University Hospital, May 2010 to March 2011 | ||
| 520 | |a PARTICIPANTS: Forty-eight American Society of Anesthesiologists I-III patients undergoing desflurane anaesthesia | ||
| 520 | |a INTERVENTION: At TOF ratio 0.6, patients were randomised to one of four treatments (physiological saline, 10, 20 or 30 µg kg(-1) neostigmine, n = 12 for each) | ||
| 520 | |a MAIN OUTCOME MEASURE: Primary efficacy endpoint: time interval between study drug injection and a TOF ratio more than 0.9 using acceleromyography. Secondary efficacy endpoint: neuromuscular recovery after 5 and 10 min | ||
| 520 | |a RESULTS: After physiological saline, the time interval [median (range)] between a TOF ratio of 0.6 and 0.9 was 14 (7 to 18) min. After 10, 20 and 30 µg kg(-1) neostigmine, it was reduced to 5 (3 to 8) min, 5 (3 to 10) and 4 (2 to 6) min, respectively (P < 0.001 compared to physiological saline). At 5 min after physiological saline, the TOF ratio [mean (SD)] was 0.73 (0.05) and 0.91 (0.06), 0.90 (0.10), 0.96 (0.02) after neostigmine 10, 20 or 30 µg kg(-1), respectively (P < 0.01 compared to physiological saline). At 10 min after physiological saline, the TOF ratio was 0.86 (0.08) and 1.0 (0), 0.98 (0.03), 1.0 (0) after neostigmine 10, 20 or 30 µg kg(-1), respectively (P < 0.01 compared to physiological saline) | ||
| 520 | |a CONCLUSION: Under desflurane anaesthesia, neostigmine 10 µg kg(-1) is effective in antagonising shallow atracurium block. Compared to no neostigmine, the time to a TOF ratio more than 0.9 was shortened and neuromuscular recovery at 5 and 10 min was more advanced | ||
| 520 | |a TRIAL REGISTRATION: EudraCT Nr. is 2009 -018214-19 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Anesthetics, Inhalation |2 NLM | |
| 650 | 7 | |a Cholinesterase Inhibitors |2 NLM | |
| 650 | 7 | |a Neuromuscular Nondepolarizing Agents |2 NLM | |
| 650 | 7 | |a Atracurium |2 NLM | |
| 650 | 7 | |a 2GQ1IRY63P |2 NLM | |
| 650 | 7 | |a Neostigmine |2 NLM | |
| 650 | 7 | |a 3982TWQ96G |2 NLM | |
| 650 | 7 | |a Desflurane |2 NLM | |
| 650 | 7 | |a CRS35BZ94Q |2 NLM | |
| 650 | 7 | |a Isoflurane |2 NLM | |
| 650 | 7 | |a CYS9AKD70P |2 NLM | |
| 700 | 1 | |a Baumann, Cedric |e verfasserin |4 aut | |
| 700 | 1 | |a De Guis, Julien |e verfasserin |4 aut | |
| 700 | 1 | |a Guerci, Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Meistelman, Claude |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of anaesthesiology |d 1993 |g 30(2013), 10 vom: 01. Okt., Seite 594-8 |w (DE-627)NLM012914576 |x 1365-2346 |7 nnns |
| 773 | 1 | 8 | |g volume:30 |g year:2013 |g number:10 |g day:01 |g month:10 |g pages:594-8 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/EJA.0b013e3283631652 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 30 |j 2013 |e 10 |b 01 |c 10 |h 594-8 | ||